DaVita Inc
NYSE:DVA

Watchlist Manager
DaVita Inc Logo
DaVita Inc
NYSE:DVA
Watchlist
Price: 149.33 USD 0.96% Market Closed
Market Cap: $10B

DaVita Inc
Non-Reccuring Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

DaVita Inc
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
DaVita Inc
NYSE:DVA
Non-Reccuring Items
-$14.2m
CAGR 3-Years
N/A
CAGR 5-Years
33%
CAGR 10-Years
32%
Quest Diagnostics Inc
NYSE:DGX
Non-Reccuring Items
-$95m
CAGR 3-Years
-1%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Non-Reccuring Items
-$5.4B
CAGR 3-Years
14%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Non-Reccuring Items
-$1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-25%
Laboratory Corporation of America Holdings
NYSE:LH
Non-Reccuring Items
-$131.5m
CAGR 3-Years
25%
CAGR 5-Years
23%
CAGR 10-Years
-1%
Guardant Health Inc
NASDAQ:GH
Non-Reccuring Items
-$4.9m
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

DaVita Inc
Glance View

In the intricate network of healthcare services, DaVita Inc. stands as a pivotal player, focusing on the often-overlooked but critical field of kidney care. Rooted in its mission to improve patients' quality of life by innovating kidney care therapies, DaVita has cultivated a robust operation primarily revolving around dialysis services. Chronic Kidney Disease (CKD) and kidney failure are rising global health concerns, necessitating regular dialysis treatments for affected individuals. DaVita serves this need through a network of dialysis centers, offering both in-center and at-home dialysis options. By prioritizing patient comfort and convenience alongside medical efficiency, DaVita has positioned itself as a go-to choice for those requiring ongoing renal care, effectively making the process as seamless as possible for patients. The business model of DaVita hinges on its ability to deliver consistent, high-quality care while managing costs—a balance crucial to success in the healthcare industry. Revenue flows in from both governmental programs such as Medicare and private health insurers, which fund the dialysis treatments for insured patients. DaVita's strategic strength lies in its operational scale, with a vast number of outpatient dialysis centers across the U.S. and internationally. This extensive reach not only strengthens its market position but also provides a wealth of data and feedback, fueling further innovation and efficiency improvements. By leveraging this extensive network, DaVita continues to tap into the growing demand for accessible, comprehensive kidney care services, reinforcing its commitment to patient-centered healthcare delivery while sustaining its financial growth.

DVA Intrinsic Value
LOCKED
Unlock

See Also

What is DaVita Inc's Non-Reccuring Items?
Non-Reccuring Items
-14.2m USD

Based on the financial report for Dec 31, 2025, DaVita Inc's Non-Reccuring Items amounts to -14.2m USD.

What is DaVita Inc's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 10Y
32%

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett